🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, open-label, single arm, non-comparative phase II tr...
Status
Terminated
Location
CHRU de Lille - Hôpital Claude Huriez
Start Date
2017-05-08
Trial ID
NCT03117361
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
The purpose of the study (retrospective and prospective) is to describe par...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2017-04-14
Trial ID
NCT03053024
The purpose of this study was to evaluate the efficacy and safety of panobi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-12-16
Trial ID
NCT02290431
Treatments Being Tested
The purpose of this study is to evaluate an investigational drug called tab...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-07
Trial ID
NCT01602224
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2012-02-15
Trial ID
NCT01497093
Treatments Being Tested
This phase II clinical trial design with a safety run-in period will be use...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-10-01
Trial ID
NCT05408026
Treatments Being Tested
The purpose of this clinical research study is to evaluate the safety and e...
Status
Terminated
Location
California Cancer Associates for Research & Excellence (cCARE)
Start Date
2014-07-07
Trial ID
NCT02188368
The purpose of this study is to evaluate the safety and effect on the body ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-07
Trial ID
NCT01556438
Treatments Being Tested
Note: The study data was transferred to zr pharma\& following the divestmen...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-27
Trial ID
NCT02654990
Treatments Being Tested